1. Home
  2. LEGN vs GXO Comparison

LEGN vs GXO Comparison

Compare LEGN & GXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • GXO
  • Stock Information
  • Founded
  • LEGN 2014
  • GXO 2021
  • Country
  • LEGN United States
  • GXO United States
  • Employees
  • LEGN N/A
  • GXO N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • GXO Transportation Services
  • Sector
  • LEGN Health Care
  • GXO Consumer Discretionary
  • Exchange
  • LEGN Nasdaq
  • GXO Nasdaq
  • Market Cap
  • LEGN 5.4B
  • GXO 4.8B
  • IPO Year
  • LEGN 2020
  • GXO N/A
  • Fundamental
  • Price
  • LEGN $35.56
  • GXO $54.61
  • Analyst Decision
  • LEGN Strong Buy
  • GXO Buy
  • Analyst Count
  • LEGN 10
  • GXO 13
  • Target Price
  • LEGN $73.67
  • GXO $60.62
  • AVG Volume (30 Days)
  • LEGN 1.1M
  • GXO 1.2M
  • Earning Date
  • LEGN 08-11-2025
  • GXO 08-05-2025
  • Dividend Yield
  • LEGN N/A
  • GXO N/A
  • EPS Growth
  • LEGN N/A
  • GXO N/A
  • EPS
  • LEGN N/A
  • GXO 0.53
  • Revenue
  • LEGN $796,838,000.00
  • GXO $12,683,000,000.00
  • Revenue This Year
  • LEGN $66.76
  • GXO $10.33
  • Revenue Next Year
  • LEGN $52.58
  • GXO $6.62
  • P/E Ratio
  • LEGN N/A
  • GXO $102.74
  • Revenue Growth
  • LEGN 74.75
  • GXO 22.39
  • 52 Week Low
  • LEGN $27.34
  • GXO $30.46
  • 52 Week High
  • LEGN $59.62
  • GXO $63.33
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 35.54
  • GXO 64.95
  • Support Level
  • LEGN $35.10
  • GXO $51.65
  • Resistance Level
  • LEGN $38.35
  • GXO $54.23
  • Average True Range (ATR)
  • LEGN 1.31
  • GXO 1.79
  • MACD
  • LEGN -0.37
  • GXO 0.14
  • Stochastic Oscillator
  • LEGN 11.33
  • GXO 95.78

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About GXO GXO Logistics Inc.

GXO Logistics Inc is a contract logistics company. Its revenue is diversified across numerous verticals and customers, including many multinational corporations. It provides warehousing and distribution, order fulfillment, e-commerce, reverse logistics, and other supply chain services differentiated by its ability to deliver technology-enabled, customized solutions at scale. Geographically, it generates revenue from the United Kingdom, the United States, the Netherlands, France, Spain, Italy, and other countries, and derives the majority of its revenue from the United Kingdom.

Share on Social Networks: